Press release from Companies

Publicerat: 2025-10-30 07:30:00

PEPTONIC Medical AB: Peptonic Medical receives part of first order from Joylux worth USD 126,000

Peptonic Medical AB (publ) ("Peptonic" or the "Company") has received part of the first order under the recently signed strategic distribution agreement with US-based Joylux Inc. The order relates to the Company’s product VagiVital AktivGel and amounts to USD 126,000. Work on design and artwork under the Joylux brand has commenced.

Joylux is a well-established player in women’s intimate self-care during and after menopause, with a strong brand, broad market presence, and an engaged community. Joylux offers effective intimate care products and innovative digital solutions that enhance women’s intimate health, and collaborates with well-known ambassadors and partners such as Respin, a company founded by actress and activist Halle Berry.

As part of the collaboration, Peptonic will supply selected products marketed and sold under the Joylux brand in the USA, Canada, Mexico, and the UK. Peptonic can now confirm that part of the first order has been received and that work on product design and artwork is well underway.

 

For further information, please contact:
Anna Linton, CEO, Peptonic Medical AB                                           

Email: anna.linton@peptonicmedical.se                                                                                     

Phone: +46 70-244 92 07

About Peptonic Medical AB                                        

PEPTONIC medical AB (publ) is a pioneering Swedish medtech company specializing in the development and sale of clinically proven self-care products for women’s intimate health. Through its brands VagiVital and Vernivia, the Company offers a broad over-the-counter portfolio of effective and gentle products designed to help women understand, treat, and prevent common medical conditions in the intimate area.

Peptonic’s growth strategy centers on geographic expansion, particularly in the U.S. and Europe, while continually enhancing its product portfolio through in-house development and strategic acquisitions.

The Company is headquartered in Stockholm, Sweden, and operates the subsidiaries, Peptonic Medical Inc. and Common Sense Marketing Inc., in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.

Läs mer hos Cision
Läs mer om PEPTONIC Medical AB